MetaCap

Immunome Inc. Company Profile

NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.69-0.92 (-5.54%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immunome at a glance

Immunome Inc. (NASDAQ: IMNM) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Bothell, WA. Immunome is led by Dr. Clay B. Siegall Ph.D. and employs about 267 people. The company's shares have traded publicly since 2020.

At a market capitalization of $1.85 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001472012, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Immunome do?

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Business description based on the company's public filings.

Company information

Legal name
Immunome Inc.
Ticker
NASDAQ: IMNM
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Clay B. Siegall Ph.D.
Employees
267
Headquarters
18702 North Creek Parkway, Bothell, WA, United States
Phone
425 939 7410
IPO year
2020
SEC CIK
0001472012
Latest annual report
10-K · Mar 3, 2026

Companies similar to Immunome

IMNM peer companies
CompanyPrice% ChgMarket capCompare
VERAVera Therapeutics Inc. Class A25.45-4.86%$1.84Bvs IMNM
SEPNSepterna Inc.38.61-1.51%$1.84Bvs IMNM
BHVNBiohaven Ltd.12.39-9.23%$1.87Bvs IMNM
MRVIMaravai LifeSciences Holdings Inc. Class A6.98-2.92%$1.81Bvs IMNM
ZYMEZymeworks Inc.26.14-2.68%$1.81Bvs IMNM
TRVITrevi Therapeutics Inc.13.35-2.70%$1.90Bvs IMNM
HRMYHarmony Biosciences Holdings Inc.32.59-1.18%$1.91Bvs IMNM
ETONEton Pharmaceuticals Inc.60.85-0.83%$1.76Bvs IMNM

Related